Hepcidin Is a Reliable Marker of Iron Deficiency Anemia in Newly Diagnosed Patients with Inflammatory Bowel Disease.

Milica Stojkovic Lalosevic Ljubisa ToncevSanja StankovicSanja DragasevicStefan StojkovicIvana JovicicMilos StulicDjordje CulaficTamara MilovanovicMarija StojanovicMarko AleksicMihailo StjepanovicJovan LalosevicStanimir KiurskiBranislav OluicAleksandra Pavlovic MarkovicMirjana Stojkovic

Published in: Disease markers (2020)

Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients.

Keyphrases

iron deficiency
newly diagnosed
clinical practice
patients with inflammatory bowel disease
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
mesenchymal stem cells
ulcerative colitis